The Department of Health and the Health Protection Agency have published the results of the first ever mandatory surveillance schemes for Clostridium difficile associated diarrhoea and glycopeptide resistant enterococci (GRE) bacteraemias. Chief nursing officer Christine Beasley said: “We added Clostridium difficile and glycopeptide resistant enterococci to the mandatory surveillance system to help the NHS establish the scale of the problem, and provide information to help improve infection control.
Other News
Latest Issues
Since 2007, Avensys has been a key player in the UK biomedical equipment market, providing device sales, repair, maintenance and training. Avensys has been part of the Fresenius Group since 2018 and, in 2025, became part of Fresenius Health Services, supporting healthcare providers with medical technology and technical infrastructure services...